G.P.Pharma International

Erbitux (Cetuximab) 5mg/mL is a monoclonal antibody used primarily to treat colorectal cancer (CRC) and head and neck cancer. It works by targeting and inhibiting the epidermal growth factor receptor (EGFR), which is often overexpressed in certain types of cancer cells. By blocking EGFR, Erbitux helps to prevent the cancer cells from growing and dividing, thus slowing or stopping the spread of cancer.

Azashine 100mg tablet contains Azacitidine, is a chemotherapy agent commonly used for treating certain blood disorders, particularly myelodysplastic syndromes (MDS) and some cases of acute myeloid leukemia (AML). As an inhibitor of DNA methyltransferase, azacitidine targets aberrant cells to halt their growth and encourage cell death.